# PRKCE

## Overview
The PRKCE gene encodes protein kinase C epsilon (PKCε), a member of the protein kinase C (PKC) family, which is a group of serine/threonine kinases involved in a wide range of cellular processes. PKCε is distinguished by its unique structural domains, including a kinase domain, a C1 domain for diacylglycerol binding, and a C2-like domain that is defective in calcium binding, which collectively contribute to its regulatory functions (Scruggs2016PRKCE; Kofler2002Molecular). This protein plays a pivotal role in cardiac physiology, particularly in cardioprotection and cardiac muscle contraction, by interacting with mitochondrial and sarcomeric proteins (Scruggs2016PRKCE). PKCε is also involved in various signaling pathways, influencing processes such as cell motility, adhesion, and mechanotransduction, and is implicated in several pathological conditions, including cancer and cardiovascular diseases (Gorin2009Protein; Scruggs2016PRKCE). The gene's alternative splicing and the protein's intracellular localization further diversify its functional roles, making it a significant target for therapeutic interventions (Scruggs2016PRKCE; Kofler2002Molecular).

## Structure
The PRKCE gene encodes the protein kinase C epsilon (PKCε), a member of the protein kinase C (PKC) family. PKCε is characterized by a molecular structure that includes a kinase domain, a C1 domain for diacylglycerol binding, and a C2-like domain that is defective in calcium binding (Kofler2002Molecular). The C2 domain is crucial for protein-protein interactions, while the C1 domain is involved in translocation, influenced by second messengers (Scruggs2016PRKCE). 

PKCε contains phosphorylation sites at Threonine-566, Threonine-710, and Serine-729, which are necessary for its maturation and activation (Scruggs2016PRKCE). These sites are involved in the priming process required for the activation of PKCε, particularly through the mTORC2 complex (Alcantara2017SHORT). 

The protein's structure also includes a Ser/Thr kinase catalytic domain and other regulatory regions, such as the pseudosubstrate autoinhibitory domain and the actin-binding domain (Alcantara2017SHORT). PKCε's spatiotemporal targeting is essential for its function, particularly in cardiomyocytes, where it plays roles at sarcomeres and mitochondria (Scruggs2016PRKCE). 

Alternative splicing of the PRKCE gene contributes to the diversity of its functions, although specific splice variants are not detailed in the provided context (Kofler2002Molecular).

## Function
The PRKCE gene encodes protein kinase C epsilon (PKCε), a serine/threonine kinase that plays significant roles in various cellular processes, particularly in cardiomyocytes. PKCε is involved in regulating cardiac muscle contraction by targeting sarcomeric proteins and modulating cardiac cell energy production and metabolism by targeting mitochondria (Scruggs2016PRKCE). In healthy hearts, PKCε forms signaling complexes with key mitochondrial proteins involved in glycolysis, the TCA cycle, beta oxidation, and ion transport pathways, contributing to cardioprotection by enhancing mitochondrial function (Scruggs2016PRKCE).

PKCε is also crucial for cardioprotection during ischemic events. It interacts with mitochondrial ATP-sensitive potassium channels (mitoK(ATP)), enhancing their opening and contributing to the preconditioning response that protects cardiac cells from ischemic injury (Scruggs2016PRKCE; Dempsey2000Protein). Additionally, PKCε plays a role in the regulation of cardiac hypertrophy through the Ras-Raf-MEK-ERK signaling pathway and is involved in mechanotransduction at cardiac sarcomeric structures (Scruggs2016PRKCE).

PKCε's activity is highly dependent on its intracellular localization, which allows for substrate selectivity and specificity. Its translocation to specific subcellular locations is facilitated by receptors for activated C-kinase (RACKs), particularly RACK2, which anchors active PKCε near its substrates (Scruggs2016PRKCE).

## Clinical Significance
PRKCE (protein kinase C epsilon) plays a significant role in various diseases due to its involvement in critical cellular processes. Alterations in PRKCE expression or mutations have been linked to several pathological conditions, including cancer, cardiovascular disorders, and neurological diseases. In cancer, dysregulation of PRKCE can affect pathways related to cell survival and apoptosis, potentially leading to uncontrolled cell proliferation and tumor development. Its role in signal transduction is crucial, and any disruption can contribute to oncogenic processes.

In cardiovascular disorders, PRKCE is implicated in the regulation of heart function and vascular homeostasis. Abnormal expression or activity of PRKCE may lead to adverse cardiac events, such as arrhythmias or heart failure, by affecting the signaling pathways that control cardiac contractility and protection against ischemic injury.

Neurologically, PRKCE is involved in processes that influence neuronal survival and inflammation. Alterations in its expression or function can contribute to neurodegenerative diseases and other neurological conditions by disrupting normal neuronal signaling and inflammatory responses. The gene's involvement in these diverse conditions underscores its importance in maintaining cellular homeostasis and highlights the potential consequences of its dysregulation.

## Interactions
Protein kinase C epsilon (PKCε), encoded by the PRKCE gene, is involved in various protein-protein interactions that influence cellular processes. PKCε interacts with the actin cytoskeleton, facilitating actin polymerization and cell spreading, which is crucial for cell motility and invasion (Gorin2009Protein). It also forms complexes with β-integrin chains and RACK1, a scaffold protein, enhancing adhesion and lamellipodia formation in glioma cells (Gorin2009Protein). In cardiomyocytes, PKCε interacts with sarcomeric proteins such as cardiac troponin I (cTnI) and cardiac troponin T (cTnT), affecting cardiac contractile function (Scruggs2016PRKCE).

PKCε is involved in signaling pathways through its interactions with mitochondrial proteins, including adenine nucleotide transporter (ANT), ATP synthase, and voltage-dependent anion channel (VDAC), which are important for cardioprotection (Scruggs2016PRKCE). It also interacts with mitochondrial ATP-sensitive potassium channels, enhancing their opening and contributing to cardioprotection (Scruggs2016PRKCE). In the context of cancer, PKCε variants have been shown to interact with Smad3, affecting oncogenic pathways in cervical cancer (Zafar2023Exploring). These interactions highlight the diverse roles of PKCε in cellular signaling and its potential as a therapeutic target.


## References


[1. (Zafar2023Exploring) Sameen Zafar, Khushbukhat Khan, Yasmin Badshah, Kanza Shahid, Janeen H. Trembley, Amna Hafeez, Naeem Mahmood Ashraf, Hamid Arslan, Maria Shabbir, Tayyaba Afsar, Ali Almajwal, and Suhail Razak. Exploring the prognostic significance of pkcε variants in cervical cancer. BMC Cancer, September 2023. URL: http://dx.doi.org/10.1186/s12885-023-11236-z, doi:10.1186/s12885-023-11236-z. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-023-11236-z)

[2. (Dempsey2000Protein) Edward C. Dempsey, Alexandra C. Newton, Daria Mochly-Rosen, Alan P. Fields, Mary E. Reyland, Paul A. Insel, and Robert O. Messing. Protein kinase c isozymes and the regulation of diverse cell responses. American Journal of Physiology-Lung Cellular and Molecular Physiology, 279(3):L429–L438, September 2000. URL: http://dx.doi.org/10.1152/ajplung.2000.279.3.l429, doi:10.1152/ajplung.2000.279.3.l429. This article has 499 citations.](https://doi.org/10.1152/ajplung.2000.279.3.l429)

[3. (Kofler2002Molecular) Kurt Kofler, Martin Erdel, Gerd Utermann, and Gottfried Baier. Molecular genetics and structural genomics of the human protein kinase c gene module. Genome Biology, February 2002. URL: http://dx.doi.org/10.1186/gb-2002-3-3-research0014, doi:10.1186/gb-2002-3-3-research0014. This article has 19 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/gb-2002-3-3-research0014)

[4. (Scruggs2016PRKCE) Sarah B. Scruggs, Ding Wang, and Peipei Ping. Prkce gene encoding protein kinase c-epsilon—dual roles at sarcomeres and mitochondria in cardiomyocytes. Gene, 590(1):90–96, September 2016. URL: http://dx.doi.org/10.1016/j.gene.2016.06.016, doi:10.1016/j.gene.2016.06.016. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.gene.2016.06.016)

[5. (Gorin2009Protein) Michael A Gorin and Quintin Pan. Protein kinase cε: an oncogene and emerging tumor biomarker. Molecular Cancer, 8(1):9, 2009. URL: http://dx.doi.org/10.1186/1476-4598-8-9, doi:10.1186/1476-4598-8-9. This article has 114 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/1476-4598-8-9)

[6. (Alcantara2017SHORT) Diana Alcantara, Frances Elmslie, Martine Tetreault, Eric Bareke, Taila Hartley, Jacek Majewski, Kym Boycott, A. Micheil Innes, David A. Dyment, and Mark O’Driscoll. Short syndrome due to a novel de novo mutation in prkce (protein kinase cɛ) impairing torc2-dependent akt activation. Human Molecular Genetics, 26(19):3713–3721, July 2017. URL: http://dx.doi.org/10.1093/hmg/ddx256, doi:10.1093/hmg/ddx256. This article has 19 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddx256)